Combined treatment with thymosin-α1 and low dose interferon-α after dacarbazine in advanced melanoma

被引:25
|
作者
Rasi, G [1 ]
Terzoli, E
Izzo, F
Pierimarchi, P
Ranuzzi, M
Sinibaldi-Vallebona, P
Tuthill, C
Garaci, E
机构
[1] CNR, Ist Med Sperimentale, I-00137 Rome, Italy
[2] Univ Rome Tor Vergata, Rome, Italy
[3] Ist Regina Elena, I-00161 Rome, Italy
[4] SciClone Pharmaceut Inc, San Mateo, CA USA
关键词
advanced melanoma; combination treatment; DTIC; interferon; thymosin-alpha; 1;
D O I
10.1097/00008390-200010020-00012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:189 / 192
页数:4
相关论文
共 50 条
  • [41] Expression of pro-angiogenic factors in malignant melanoma and their regulation by low-dose interferon-α
    M. Go
    J. Biber
    G. B. Lesinski
    W. E. Carson
    Annals of Surgical Oncology, 2004, 11 : S122 - S122
  • [42] COMBINED INTERFERON AND VINBLASTINE TREATMENT OF ADVANCED MELANOMA AND RENAL-CELL CANCER
    KELLOKUMPULEHTINEN, P
    NORDMAN, E
    CANCER DETECTION AND PREVENTION, 1988, 12 (1-6): : 523 - 529
  • [43] DOSE-ESCALATION OF DACARBAZINE COMBINED WITH INTERFERON ALPHA-2A, G-CSF AND ONDANSETRON IN PATIENTS WITH METASTATIC MELANOMA
    BUTER, J
    SLEIJFER, DT
    WILLEMSE, PHB
    VANDERGRAAF, WTA
    DEVRIES, EGE
    KOOPS, HS
    MULDER, NH
    ANTICANCER RESEARCH, 1994, 14 (3B) : 1325 - 1328
  • [44] A randomized controlled clinical trial on the treatment of Thymosin-a1 versus interferon-α in patients with hepatitis B
    You, J
    Zhuang, L
    Tang, BZ
    Yang, WB
    Ding, SY
    Li, W
    Wu, RX
    Zhang, HL
    Zhang, YM
    Yan, SM
    Zhang, L
    WORLD JOURNAL OF GASTROENTEROLOGY, 2001, 7 (03) : 411 - 414
  • [45] A randomized controlled clinical trial on the treatment of Thymosin-a1 versus interferon-α in patients with hepatitis B
    Jing You Lin Zhuang Bao Zhang Tang Wei Bo Yang Su Ying Ding Wu Li Rong Xue Wu Hong Li Zhang Yan Mei Zhang Shao Ming Yan Lu Zhang ~1Department of Infectious Diseases
    World Journal of Gastroenterology, 2001, (03) : 411 - 414
  • [46] Interferon-α1b for the treatment of metastatic melanoma: results of a retrospective study
    Shi, Qiong
    Liu, Lin
    Zhang, Weigang
    Zhao, Yanhong
    Liu, Yu
    Zhu, Guannan
    Guo, Weinan
    Zhao, Tao
    Zhao, Jianhong
    Wang, Lei
    Li, Chunying
    Gao, Tianwen
    ANTI-CANCER DRUGS, 2021, 32 (10) : 1105 - 1110
  • [48] Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: A phase-II controlled trial
    Salvati, F
    Rasi, G
    Portalone, L
    Antilli, A
    Garaci, E
    ANTICANCER RESEARCH, 1996, 16 (02) : 1001 - 1004
  • [49] COMBINED INTERFERON AND VINBLASTINE TREATMENT OF ADVANCED MELANOMA - EVALUATION OF THE TREATMENT RESULTS AND THE EFFECTS OF THE TREATMENT ON IMMUNOLOGICAL FUNCTIONS
    KELLOKUMPULEHTINEN, P
    NORDMAN, E
    TOIVANEN, A
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1989, 28 (03) : 213 - 217
  • [50] Low-dose natural human interferon-α lozenges in the treatment of Behcet's syndrome
    Kilic, Hasan
    Zeytin, Hasan E.
    Korkmaz, Cengiz
    Mat, Cem
    Gul, Ahmet
    Cosan, Fulya
    Dinc, Ayhan
    Simsek, Ismail
    Sut, Necdet
    Yazici, Hasan
    RHEUMATOLOGY, 2009, 48 (11) : 1388 - 1391